ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >Everolimus Ring-Opening Impurity

Everolimus Ring-Opening Impurity

Everolimus Ring-Opening Impurity Structure
CAS No.
1708118-13-1
Chemical Name:
Everolimus Ring-Opening Impurity
Synonyms
Everolimus Impurity 33;Everolimus Impurity 012-99;Everolimus Open-Ring Impurity;Everolimus Impurity 2(012-99);Everolimus Impurity 3 (012-99);Everolimus Open-Ring Aldehyde Impurity;EverolimusRetroaldolDegradationProduct;(S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-hydroxyethoxy);Everolimus Ring-Opening Impurity (Mixture of Isomers);(S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate
CBNumber:
CB02737607
Molecular Formula:
C53H83NO14
Molecular Weight:
958.22442
MOL File:
1708118-13-1.mol
Modify Date:
2023/4/23 13:52:06

Everolimus Ring-Opening Impurity Properties

Melting point 45-50°C
storage temp. Amber Vial, -86°C Freezer, Under inert atmosphere
solubility Chloroform (Slightly), Methanol (Slightly)
form Solid
color White to Off-White
Stability Light and temperature Sensitive

Everolimus Ring-Opening Impurity Chemical Properties,Uses,Production

Uses

Everolimus Retroaldol Degradation Product is an impurity of Everolimus (E945400). Everolimus is a derivative of Rapamycin. Everolimus inhibits cytokine-mediated lymphocyte proliferation. Everolimus Impurity D

Everolimus Ring-Opening Impurity Preparation Products And Raw materials

Raw materials

Preparation Products

EverolimusRetroaldolDegradationProduct (S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-hydroxyethoxy) Everolimus Impurity 012-99 Everolimus Open-Ring Impurity Everolimus Open-Ring Aldehyde Impurity Everolimus Impurity 33 (2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl (S)-1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate (S)-(2R,3S,6R,E)-1-((1S,3R,4R)-4-(2-Hydroxyethoxy)-3-methoxycyclohexyl)-2,6,8-trimethyl-5,9-dioxonon-7-en-3-yl 1-(2-((2R,3R,6S)-6-((2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxotrideca-3,5,7-trien-1-yl)-2-hydroxy-3-methyltetrahydro-2H-pyran-2-yl)-2-oxoacetyl)piperidine-2-carboxylate Everolimus Impurity 2(012-99) 2-Piperidinecarboxylic acid, 1-[2-[(2R,3R,6S)-6-[(2S,3E,5E,7E,9S,11R)-2,13-dimethoxy-3,9,11-trimethyl-12-oxo-3,5,7-tridecatrien-1-yl]tetrahydro-2-hydroxy-3-methyl-2H-pyran-2-yl]-2-oxoacetyl]-, (1S,4R,5E)-1-[(1R)-2-[(1S,3R,4R)-4-(2-hydroxyethoxy)-3-methoxycyclohexyl]-1-methylethyl]-4,6-dimethyl-3,7-d... Everolimus Ring-Opening Impurity (Mixture of Isomers) Everolimus Impurity 3 (012-99) 1708118-13-1